Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This is the first study in humans to evaluate the effectiveness of SJP‐0132 in the treatment of dry eye disease. This study will evaluate the safety, tolerability, efficacy, and pharmacokinetics of single‐ and multiple‐dose regimens of SJP‐0132 in subjects with dry eye disease
Epistemonikos ID: ff0ea801b36af8d178307dc59fcfde638089c809
First added on: May 06, 2024